Intra-Cellular Therapies Reports Strong Financial Results and Corporate UpdateIntra-Cellular Therapies, a biopharmaceutical company specializing in the development and commercialization of therapeutics for central nervous system disorders,

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Intra-Cellular Therapies’s 8K filing here. About Intra-Cellular Therapies (Get Free Report) Intra-Cellular Therapies, Inc, a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical […]

Leave a Reply

Your email address will not be published.

Previous post Littelfuse’s (LFUS) Hold Rating Reaffirmed at Benchmark
Next post USCB Financial Announces Quarterly Cash Dividend Declaration